Venus Concept Past Earnings Performance
Past criteria checks 0/6
Venus Concept has been growing earnings at an average annual rate of 2.6%, while the Medical Equipment industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 2.8% per year.
Key information
2.6%
Earnings growth rate
57.3%
EPS growth rate
| Medical Equipment Industry Growth | 8.9% |
| Revenue growth rate | -2.8% |
| Return on equity | n/a |
| Net Margin | -48.8% |
| Next Earnings Update | 15 May 2024 |
Recent past performance updates
Recent updates
Revenue & Expenses BreakdownBeta
How Venus Concept makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Dec 23 | 76 | -37 | 72 | 8 |
| 30 Sep 23 | 83 | -36 | 76 | 9 |
| 30 Jun 23 | 86 | -42 | 81 | 10 |
| 31 Mar 23 | 94 | -45 | 87 | 11 |
| 31 Dec 22 | 99 | -44 | 90 | 11 |
| 30 Sep 22 | 108 | -38 | 91 | 12 |
| 30 Jun 22 | 111 | -33 | 90 | 11 |
| 31 Mar 22 | 109 | -22 | 85 | 10 |
| 31 Dec 21 | 106 | -23 | 82 | 10 |
| 30 Sep 21 | 99 | -33 | 80 | 8 |
| 30 Jun 21 | 95 | -31 | 74 | 8 |
| 31 Mar 21 | 86 | -44 | 72 | 7 |
| 31 Dec 20 | 78 | -85 | 74 | 8 |
| 30 Sep 20 | 84 | -91 | 88 | 8 |
| 30 Jun 20 | 90 | -93 | 97 | 8 |
| 31 Mar 20 | 100 | -86 | 103 | 9 |
| 31 Dec 19 | 110 | -41 | 99 | 8 |
| 30 Sep 19 | 107 | -33 | 84 | 8 |
| 30 Jun 19 | 107 | -26 | 78 | 8 |
| 31 Mar 19 | 106 | -19 | 71 | 8 |
| 31 Dec 18 | 103 | -15 | 67 | 7 |
| 31 Dec 17 | 89 | 3 | 50 | 6 |
| 31 Dec 16 | 53 | -13 | 42 | 5 |
Quality Earnings: VERO is currently unprofitable.
Growing Profit Margin: VERO is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VERO is unprofitable, but has reduced losses over the past 5 years at a rate of 2.6% per year.
Accelerating Growth: Unable to compare VERO's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VERO is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.5%).
Return on Equity
High ROE: VERO's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.